Structure-based design of novel melanin-concentrating hormone receptor-1 ligands based on saturated nitrogencontaining heterocycles.
暂无分享,去创建一个
[1] Kaichao You,et al. Identification and New Indication of Melanin-Concentrating Hormone Receptor 1 (MCHR1) Antagonist Derived from Machine Learning and Transcriptome-Based Drug Repositioning Approaches , 2022, International journal of molecular sciences.
[2] J. Éles,et al. hERG optimization of MCHR1 antagonist benzofuro-pyridine and pyrazino-indole derivatives. , 2022, ChemMedChem.
[3] Shan Bian,et al. Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein , 2021, Frontiers in Endocrinology.
[4] S. Nauli,et al. Regulation of Brain Primary Cilia Length by MCH Signaling: Evidence from Pharmacological, Genetic, Optogenetic, and Chemogenic Manipulations , 2021, Molecular Neurobiology.
[5] E. Proschak,et al. Spirocyclic Scaffolds in Medicinal Chemistry. , 2020, Journal of medicinal chemistry.
[6] M. Avery,et al. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. , 2019, Bioorganic & medicinal chemistry letters.
[7] Marshall J. Allen,et al. Synthetic Studies Toward Bazzanin K: Regioselective and Chemoselective Three-Component Suzuki Coupling. , 2019, The Journal of organic chemistry.
[8] A. Gundlach,et al. Melanin-concentrating hormone and orexin systems in rat nucleus incertus: Dual innervation, bidirectional effects on neuron activity, and differential influences on arousal and feeding , 2018, Neuropharmacology.
[9] Douglas J. MacNeil,et al. The Role of Melanin-Concentrating Hormone and Its Receptors in Energy Homeostasis , 2013, Front. Endocrinol..
[10] S. Waldman,et al. Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy , 2010, Clinical pharmacology and therapeutics.
[11] B. Yates,et al. Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons , 2010, Brain Research.
[12] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[13] Jill M. Wetter,et al. Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. , 2008, Journal of medicinal chemistry.
[14] J. Bittencourt,et al. Anatomy, function and regulation of neuropeptide EI (NEI) , 2008, Peptides.
[15] Shuhui Chen,et al. Practical Synthesis of Structurally Important Spirodiamine Templates , 2007 .
[16] V. McKee,et al. Spirobicyclic Diamines. Part 3: Synthesis and Metal Complexation of Proline-Derived (4,4)- Spirodiamines. , 2007 .
[17] M. J. Bishop,et al. 6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist. , 2006, Journal of medicinal chemistry.
[18] G. Diaz,et al. Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety. , 2006, Journal of medicinal chemistry.
[19] Hui-qiang Zhou,et al. Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. , 2006, Journal of medicinal chemistry.
[20] Thomas Fey,et al. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists. , 2005, Journal of medicinal chemistry.
[21] Michael Czarniecki,et al. Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis. , 2005, Bioorganic & medicinal chemistry.
[22] H. Iwaasa,et al. Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. , 2003, American journal of physiology. Endocrinology and metabolism.
[23] E. Giralt,et al. Spirolactams as conformationally restricted pseudopeptides: synthesis and conformational analysis. , 2002, The Journal of organic chemistry.
[24] Beth Borowsky,et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.
[25] H. Hsiung,et al. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. , 2002, Endocrinology.
[26] Yuji Ishihara,et al. T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. , 2002, European journal of pharmacology.
[27] Yue Feng,et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] W Li,et al. Identification and characterization of a melanin-concentrating hormone receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Chambers,et al. Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor* , 2001, The Journal of Biological Chemistry.
[30] B. Lowell,et al. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.
[31] L. Slieker,et al. Melanin-concentrating hormone receptor is a target of leptin action in the mouse brain. , 2001, Endocrinology.
[32] J. Chambers,et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 , 1999, Nature.
[33] Yumiko Saito,et al. Molecular characterization of the melanin-concentrating-hormone receptor , 1999, Nature.
[34] W. B. Gleason,et al. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide. , 1999, Journal of medicinal chemistry.
[35] B. Lowell,et al. Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.
[36] J. Germanas,et al. Novel Bicyclic Lactams as XaaPro Type VI beta Turn Mimics: Design, Synthesis, and Evaluation. , 1996, The Journal of organic chemistry.
[37] S. Gammeltoft,et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.
[38] J. Vaughan,et al. The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.
[39] J H Welsh,et al. Synthesis, conformational properties, and antibody recognition of peptides containing beta-turn mimetics based on alpha-alkylproline derivatives. , 1991, Journal of medicinal chemistry.
[40] J R Brown,et al. Potent and highly selective neurokinin antagonists. , 1990, Journal of medicinal chemistry.
[41] F. Faigl,et al. A CONVENIENT METHOD FOR OPTICAL RESOLUTIONS VIA DIASTEREOISOMERIC SALT FORMATION , 1985 .